244 related articles for article (PubMed ID: 33324676)
1. The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
Wei T; Bi G; Bian Y; Ruan S; Yuan G; Xie H; Zhao M; Shen R; Zhu Y; Wang Q; Yang Y; Zhu D
Front Mol Biosci; 2020; 7():565383. PubMed ID: 33324676
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
Front Genet; 2020; 11():547. PubMed ID: 32595698
[TBL] [Abstract][Full Text] [Related]
3. A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancers.
Liu Y; Ye G; Dong B; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Qi Y
Ann Transl Med; 2022 Mar; 10(6):279. PubMed ID: 35433956
[TBL] [Abstract][Full Text] [Related]
4. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer.
Gao W; Liu D; Sun H; Shao Z; Shi P; Li T; Yin S; Zhu T
BMC Cancer; 2022 Dec; 22(1):1367. PubMed ID: 36585688
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of
Li B; Li X; Yang Q; Jiang Y; Zhang Q; Zhang J; Cui W; Xu F
Aging (Albany NY); 2024 Feb; 16(3):2953-2977. PubMed ID: 38329443
[TBL] [Abstract][Full Text] [Related]
6. Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers.
Zeng P; Zhang X; Xiang T; Ling Z; Lin C; Diao H
Bioengineered; 2022 Feb; 13(2):3221-3239. PubMed ID: 35067176
[TBL] [Abstract][Full Text] [Related]
7. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
8. The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis.
Zheng Y; Hao S; Xiang C; Han Y; Shang Y; Zhen Q; Zhao Y; Zhang M; Zhang Y
Front Oncol; 2021; 11():592854. PubMed ID: 34178613
[TBL] [Abstract][Full Text] [Related]
9. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.
Li S; Yang R; Sun X; Miao S; Lu T; Wang Y; Wo Y; Jiao W
Gene; 2018 Dec; 679():398-404. PubMed ID: 30240883
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis reveals alcohol dehydrogenase 1C and secreted phosphoprotein 1 for prognostic biomarkers in lung adenocarcinoma.
Shen XY; Liu XP; Song CK; Wang YJ; Li S; Hu WD
J Cell Physiol; 2019 Dec; 234(12):22311-22320. PubMed ID: 31074035
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis to Identify
Zhao K; Ma Z; Zhang W
Front Genet; 2021; 12():732822. PubMed ID: 35058964
[No Abstract] [Full Text] [Related]
12. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.
Bie T; Zhang X
J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
14. Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.
Li M; Wang K; Pang Y; Zhang H; Peng H; Shi Q; Zhang Z; Cui X; Li F
Med Sci Monit; 2020 Mar; 26():e920355. PubMed ID: 32208405
[TBL] [Abstract][Full Text] [Related]
15. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer.
Deepti P; Pasha A; Kumbhakar DV; Doneti R; Heena SK; Bhanoth S; Poleboyina PK; Yadala R; S D A; Pawar SC
Gene; 2022 May; 824():146381. PubMed ID: 35271951
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z
Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066
[TBL] [Abstract][Full Text] [Related]
18. Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.
Tu Y; Chen C; Fan G
BMC Cancer; 2019 Dec; 19(1):1230. PubMed ID: 31849319
[TBL] [Abstract][Full Text] [Related]
19. Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics Analysis.
Nedjadi T; Ahmed ME; Ansari HR; Aouabdi S; Al-Maghrabi J
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067407
[TBL] [Abstract][Full Text] [Related]
20. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
